Target intelligence / Profile preview

Purinergic Receptor P2Y Family (P2Y)

Target
P2Y
Molecular classification
G protein-coupled receptor, GPCR, Receptor
01

Overview

The purinergic receptor P2Y family comprises a group of G protein-coupled receptors (GPCRs) activated by extracellular nucleotides, including ATP, ADP, UTP, UDP, and UDP-glucose. They play key roles in purinergic signaling, regulating diverse physiological processes through different subtypes (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14) that vary in ligand specificity, G protein coupling, tissue distribution, and function. These receptors are involved in platelet aggregation, neuronal activity modulation, microglial function, inflammation regulation, and potentially neurodegenerative diseases. Drugs targeting specific P2Y subtypes, such as antiplatelet agents targeting P2Y12, have been developed for clinical use.

Other names
P2Y receptorsPurinergic P2Y receptorsP2YR
02

Mechanism of action

Agonist or antagonist at specific P2Y receptor subtypes, modulating downstream signaling pathways such as PLC activation, IP3/DAG production, Ca2+ release, adenylyl cyclase inhibition, and cAMP reduction.

03

Biological functions

Signal transductionPlatelet aggregationModulation of neuronal activityMicroglial migrationMicroglial phagocytosisInflammation regulation
04

Disease associations

Cardiovascular diseaseInflammationNeurodegenerative diseaseAlzheimer's disease
05

Safety considerations

Potential for off-target effects due to sequence homology with other GPCRs.Varied expression patterns across cell types making it challenging to predict effects of therapeutics.
06

Interacting drugs

Clopidogrel

5 more in the full profile.

Beyond the preview

Go deeper on Purinergic Receptor P2Y Family (P2Y).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purinergic Receptor P2Y Family (P2Y).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call